Since 2015, the Levine Cancer Institute, Atrium Health, has created and utilized the Electronically Accessible Pathways, which has helped drive standardization and enhance provider and patient diagnostic and treatment knowledge across its regional network.
Researchers identified critical educational gaps that need to be addressed by manufacturers and policymakers in order for biosimilars to achieve their potential for lowering the cost of cancer care in the United States.
Express Scripts recently announced the purchase of eviCore, a leading medical benefits management firm, for $3.6 billion. The merger has the potential to be the first comprehensive care management offering.
Biosimilars occupy a huge place in the oncology treatment conversation these days. But what are they exactly, and how will they impact clinical pathways?
In this article, the author discusses the most prominent value frameworks that have been recently developed and compare each of their methods for defining value.
The authors discuss tactics for ensuring appropriate compliance with clinical pathways among health care providers in large-scale health networks.
Clinical pathways are intended to be used by a multidisciplinary health care team in order to achieve the Triple Aim of healthcare reform.